PAI-1 and diabetes: a journey from the bench to the bedside

Diabetes Care. 2012 Oct;35(10):1961-7. doi: 10.2337/dc12-0638.

Authors

David J Schneider¹, Burton E Sobel

Affiliation

¹ Cardiovascular Unit, Department of Medicine, University of Vermont Colchester Research Facility, Colchester, Vermont, USA. david.schneider@uvm.edu

No abstract available

MeSH terms

Angioplasty, Balloon, Coronary / adverse effects
Animals
Coronary Artery Bypass / adverse effects
Coronary Artery Disease / etiology*
Coronary Artery Disease / surgery
Diabetes Mellitus, Type 2 / blood
Diabetes Mellitus, Type 2 / complications*
Fibrinolysis / drug effects
Humans
Insulin / therapeutic use
Insulin Resistance / physiology
Male
Myocardial Infarction / etiology
Obesity / complications
Plasminogen Activator Inhibitor 1 / biosynthesis
Plasminogen Activator Inhibitor 1 / physiology*
Rabbits
Randomized Controlled Trials as Topic
Tissue Plasminogen Activator / antagonists & inhibitors
Tissue Plasminogen Activator / physiology

Substances

Insulin
Plasminogen Activator Inhibitor 1
Tissue Plasminogen Activator